Best Guam Grants for Nonprofits

The Institutional Translational Research Training Program (T32) aims to prepare trainees for advancing basic research into clinical applications. This program focuses on developing essential skills in experimental design, statistical analysis, and effective science communication. Participants, including advanced predoctoral students and postdoctoral fellows, will engage in a two-year training program that fosters collaboration among neuroscientists and clinicians, ultimately equipping them to tackle basic research challenges and translate discoveries into viable therapies.

The NIH Mentored Clinical Scientist Research Career Development Award (K08) aims to develop the research careers of individuals with clinical doctoral degrees. This program provides essential support and protected time for intensive, supervised research experiences in biomedical and behavioral fields, including translational research. Important deadlines for applications span from June 2024 to February 2027, accommodating various grant types, including standard and AIDS-related applications.

The NIH Mentored Clinical Scientist Research Career Development Award (K08) supports individuals with clinical doctoral degrees in conducting significant health-related research. This program provides essential funding and protected time for intensive research career development in biomedical and behavioral fields, including translational research. Key deadlines for applications range from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related applications. This initiative aims to enhance the nation's research capacity and address critical health needs.

The Mentored Clinical Scientist Research Career Development Award (K08) supports individuals with clinical doctoral degrees to pursue intensive research training. This program focuses on developing skills in biomedical and behavioral research, addressing national health-related research needs. Key deadlines for applications span from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related grants, ensuring that qualified candidates have ample opportunity to apply and advance their research careers.

The National Institute on Aging (NIA) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing the discovery of in vivo chemical probes for brain targets. Collaborating institutes include the National Eye Institute (NEI), National Institute on Drug Abuse (NIDA), and National Institute of Mental Health (NIMH). The initiative seeks to foster research into small molecules and novel biological targets related to brain diseases, encouraging innovative projects and collaborations.

The NIH Independent Scientist Award (K02) aims to support the development of independent scientists and enhance their research capabilities. This award offers salary support and protected time for three to five years, specifically for those leading independent clinical trials or feasibility studies. Applicants must demonstrate a need for focused research to advance their careers. Key deadlines for applications span from June 2024 to February 2027, catering to various submission types including standard and AIDS-related grants.

The EPSCoR Research Infrastructure Improvement-Focused Collaborations Program (RII-FEC) aims to enhance research capabilities in eligible jurisdictions by fostering partnerships among government, higher education, and industry. This program supports interdisciplinary teams of researchers to tackle significant challenges in STEM fields, promoting diversity and broadening participation. By integrating Minority-Serving Institutions and early-career faculty from underrepresented backgrounds, RII-FEC seeks to build sustainable STEM capacity and drive impactful discoveries across regions.

The Clinician Scientist Development Grant (CSDG) by the American Cancer Society supports full-time faculty aiming to become independent clinician scientists while maintaining clinical practice. Eligible applicants must hold a doctoral degree, an active clinical license, and have clinical care experience. The grant provides funding of $135,000 annually for 3 to 5 years, including allowable indirect costs, to advance cancer research in key priority areas.

The American Cancer Society's Mentored Research Grants for Postdoctoral Fellowships (PF) aim to support emerging researchers in their training programs, fostering their transition to independent cancer research careers. Eligible candidates include US citizens or non-citizens with valid visas who have completed their doctoral degrees within the last four years. The fellowship offers funding for up to three years, with stipends of $66,000 to $70,000 annually, alongside allowances for health insurance and professional development.

The Limited Competition: Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program aims to enhance the research capacity of resource-limited institutions. By focusing on essential areas like biomedical research environment and sponsored programs administration, this initiative seeks to foster rigorous and reproducible biomedical research. Eligible organizations are encouraged to submit proposals addressing their specific needs, thereby expanding the pool of qualified researchers and strengthening the settings for NIH-funded research.

The Mission Boost Grants (MBG) by the American Cancer Society aim to enhance cancer research by funding projects that translate into human testing. These grants support investigators at all levels, offering resources for innovative clinical projects. The program consists of two funding stages: Stage I focuses on developing clear milestones for new treatments, while Stage II supports patient testing, ultimately contributing to advancements in cancer care and treatment.

This funding opportunity aims to support research interventions that enhance health outcomes in Native American populations. It focuses on addressing significant health disparities through culturally informed research, including the development and testing of health promotion strategies and treatment interventions. The initiative encourages sustainable solutions tailored to community needs, leveraging existing strengths and resources to improve health equity and reduce disease morbidity and mortality. Applications are due on multiple deadlines from 2024 to 2027.

The NIDA invites applications for longitudinal cohort studies focusing on the interplay between HIV/AIDS and substance use. This initiative aims to support multi-disciplinary research that informs policies and practices to address HIV-related health issues. The program encourages both existing and new sites to pursue high-priority research questions, fostering collaboration with a dedicated Coordinating Center. All applications must be submitted by the specified deadline to be considered for funding.

This funding opportunity aims to enhance health interventions for Native American populations, addressing significant disease inequities and unique sociopolitical factors. It supports research in developing, adapting, and testing culturally informed health strategies, ensuring sustainability and community involvement. Key deadlines for applications are October 21, 2024, 2025, and 2026 for standard grants, and January 7, 2025, 2026, and 2027 for AIDS-related grants, emphasizing timely participation.

The Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) aims to support exploratory studies that enhance health promotion and disease prevention for Native American populations. This initiative encourages research addressing significant health inequities and sociopolitical challenges faced by these communities. By fostering culturally informed interventions, the program seeks to develop scalable solutions to improve health outcomes and reduce morbidity and mortality among Alaska Natives, American Indians, and Native Hawaiians.

The Live Your Dream Awards, sponsored by Soroptimist International of the Americas, empower women by providing vital monetary assistance for their education and training. Each year, over $3 million is awarded to more than 2,300 women who are the primary financial support for their families. This initiative supports those overcoming significant challenges like poverty and domestic violence, ensuring they have the resources to achieve their dreams and live fulfilling lives.

The AHRQ funding opportunity invites proposals to enhance diagnostic safety in ambulatory care settings. The initiative aims to investigate the incidence and causes of diagnostic errors across diverse ambulatory services. Researchers are encouraged to explore innovative approaches and methodologies to improve diagnostic accuracy and patient outcomes, contributing significantly to healthcare quality and safety. All applications must be submitted by 5:00 PM local time of the applicant's organization.

The AHRQ Improving Diagnostic Safety in Ambulatory Care (R18) program invites proposals aimed at enhancing diagnostic safety within the diverse ambulatory care landscape. This funding initiative seeks to support the development, testing, and evaluation of interventions designed to improve diagnostic quality and safety, addressing the complexities of outpatient care. Applications are due by 5:00 PM local time of the applicant organization, emphasizing the importance of timely submission.

The NSF SBIR/STTR programs are launching a pilot emphasis on advancing scientific instrumentation and enabling technologies to drive innovation and economic growth in the U.S. This initiative supports startups and small businesses developing critical scientific equipment and platforms, with funding opportunities up to $2 million for R&D. By prioritizing next-generation instrumentation, NSF aims to enhance the scientific enterprise and foster breakthroughs essential for the future of AI-driven discoveries and broader scientific advancements.

The National Institutes of Health (NIH) is inviting applications for the Screening, Brief Intervention, and Referral to Treatment or Prevention (SBIRT/P) program. This initiative aims to address alcohol, tobacco, and other drug use in adult populations facing health disparities. The application deadlines span from February 2024 to March 2027, focusing on innovative strategies for implementing SBIRT/P, which includes screening, intervention, and referral for treatment. Collaborative efforts with healthcare and community partners are encouraged.

The DoW Orthopaedic Applied Research Award supports innovative research aimed at improving treatment and functionality for individuals with combat-related orthopaedic injuries. Applicants are required to present preliminary data and focus on applied research that evaluates new solutions, including pharmacologic agents and rehabilitation techniques. This initiative emphasizes the importance of military relevance, aiming to benefit Service Members, their families, and Veterans, while clinical research proposals are not permitted.

The FY26 Orthopaedic Research Program Clinical Research Award supports vital clinical research addressing orthopaedic-specific factors and interventions. It aims to generate evidence that optimizes patient outcomes and informs clinical care, benefiting Service Members, Veterans, and the public. Applications should focus on priority areas such as Ligamentous Trauma and Military Women’s Health, ensuring significant impact on patient care and mitigation of orthopaedic injuries.

The FY26 Autism Research Program Clinical Trial Award aims to rapidly implement clinical trials that significantly impact autism treatment and management. Projects may range from small proof-of-concept trials to large-scale studies assessing efficacy in relevant populations. Applications are encouraged to partner experienced and early-career investigators and must include community collaborations to enhance research impact. At least one community partner is required to provide ongoing consultation throughout the project.

The FY26 Autism Research Program's Idea Development Award from the US DOD aims to support groundbreaking research that improves outcomes for Autistic individuals. This award encourages innovative, high-risk projects that can lead to significant advancements in autism research. Applications must address specific areas of interest or justify the importance of the research problem. A unique Partnering Principal Investigator option allows two researchers to collaborate on a single project, enhancing the potential for impactful discoveries.

The FY26 Autism Research Program Career Development Award aims to support early-career investigators in conducting innovative research that can significantly impact autism. It encourages applications addressing specific areas of interest and mandates community collaboration for projects involving pilot clinical trials. Proposals must include partnerships with community members for effective planning and implementation, ensuring that the research is grounded in the needs of the autism community.

The Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) program invites applications focused on revolutionary breakthroughs in cancer biology and oncology through nanotechnology. Projects should tackle significant challenges in these fields while emphasizing mechanistic studies of nanomaterials and devices. The aim is to enhance understanding of their interactions with biological systems, particularly in delivering nanoparticles to cancer targets, thus laying the groundwork for future nanotechnology-based interventions.

About

Paul Newman was born and raised in Ohio by parents who owned a successful sporting goods store. He enlisted in the Navy and completed his military service as a radioman/gunner in the Pacific during World War II. Seeing his father’s business ethic during the Great Depression and experiencing the war fueled his desire to help others in need.

In 1958, Paul made his acting debut on Broadway in “Picnic,” where he also met his future wife, Joanne Woodward. Paul started a successful race car driving career inspired by training for the film Winning. He went on to win second place in the 24 Hours of Le Mans, the world’s oldest endurance race event. After years of acting and being recognized for his achievements on screen and stage, he received many accolades including an Oscar for Best Actor in The Color of Money.

Paul used his fame for good. He was dedicated to civil rights–attending the March on Washington in August 1963–women’s rights, and gay rights. He used his platform to advocate for equal pay for his female co-stars. He was a vocal political advocate committed to ending the nuclear arms race and determined to elect opponents of war and militarism. President Jimmy Carter appointed him to a United Nations General Assembly session on nuclear disarmament.

In 1982, Paul Newman and his friend Hotch founded a food company on a bit of a lark. They turned a profit selling salad dressing that first year, and did something truly radical when they decided to “give it all away” to good causes.

Paul established Newman’s Own Foundation to ensure the continuation of his philanthropic legacy after his passing. 40+ years since its founding, his first of its kind food company and its innovative business model are still going strong.

Garden Grants

Through Whole Foods Market’s Garden Grant program, schools turn outdoor spaces into powerful hands-on learning gardens that connect kids with food, spark their curiosity and support classroom curriculum.